Trial
NCT04949425
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Advanced Solid Tumours
Intervention
Adavosertib
Why stopped
Study terminated because the clinical development programme for Adavosertib has been discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-02